1d
Medindia on MSNJapan's Stem Cell Miracle: Paralyzed Man Walks UnassistedStem cell treatment using reprogrammed cells shows promising in helping paralyzed individuals regain lost functions.
A Japanese patient paralyzed for years can now stand unaided after participating in a groundbreaking clinical trial using ...
1d
Business and Financial Times on MSNStem cell therapy best bet at reducing rising NCD burden – ExpertDr. Davies Kofie Adedze, a leading advocate for regenerative medicine, has stated that stem cell therapy could significantly ...
Kwame was only 29 when he was told he needed spinal surgery. Years of back pain had worsened into something unbearable—his ...
2d
Sinar Daily on MSNStem cell treatment helped improve spinal cord injuries: Japan scientistsResearchers at Tokyo's Keio University are conducting their study using induced pluripotent stem cells (iPS) -- created by ...
The global Plant Stem Cells Market, valued at US$ 396.1 million in 2023, is poised for robust expansion, projected to reach a market size of US$ 855.3 million by 2032. This growth ...
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan's research ...
Mesoblast develops allogeneic products based on its proprietary remestemcel-L and rexlemestrocel-L mesenchymal lineage stromal and precursor cell platform technologies. Its allogeneic cellular ...
Japan’s leading chemical producers are in the midst of a restructuring intended to shift their focus from traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results